Not Signed In - Pain Therapeutics Announces Positive Phase I Study Results With PTI-202
Thu, 30 Nov 2006 08:00 AM EST
... Pain Therapeutics, Inc. (Nasdaq: PTIE) announced positive results today from a Phase I clinical trial evaluating PTI-202, the Company's second abuse- resistant opioid painkiller. This clinical trial was designed to investigate the safety, tolerability, pharmacokinetics and pharmacodynamic profile of a single, oral dose of PTI-202 in healthy volunteers. [click link for full article] ...
Related Topics
- Pain
- Chronic Pain
- Pain - Chronic
- Pain Control
- Pain, Chest
- Chest Pain
- Low Back Pain
- Pharmacology
- Back Pain
- Abdominal Pain
- Food Recommendations: South Beach Diet - Phase 2
- Food Recommendations: South Beach Diet - Phase 1
- Tb
- Urinalysis
- Sciatica
- Complex Regional Pain Syndrome
- Radiation Studies
- HLA-B27
- Triple Screen
- TB Skin Test
email this page
print this page
bookmark this page
feedback on this page
